All news. http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Thu, 11 Mar 2010 03:00:39 +0100 Thu, 11 Mar 2010 03:00:39 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online INSYS Therapeutics Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray http://www.lifescience-online.com/INSYS_Therapeutics_Announces_Positive_Phase_III_Ef,20224.html?portalPage=Lifescience+Today.News
Category :
Scientific - Pipeline - Regulatory

Related companies :
INSYS THERAPEUTICS INC

Related drugs :
FENTANYL SUBLINGUAL SPRAY


]]> Mon, 08 Mar 2010 23:00:00 GMT News Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial http://www.lifescience-online.com/Aastrom_Announces_Treatment_of_Final_Patient_in_IM,20226.html?portalPage=Lifescience+Today.News
Area :
Musculoskeletal System

Category :
Scientific - Pipeline - Regulatory

Related companies :
AASTROM BIOSCIENCES INC

Related drugs :
TISSUE REPAIR CELL


]]> Mon, 08 Mar 2010 23:00:00 GMT News Ischemix Initiates Phase 2a Trial of CMX-2043 for the Prevention of Ischemia-Reperfusion Injury http://www.lifescience-online.com/Ischemix_Initiates_Phase_2a_Trial_of_CMX_2043_for_,20227.html?portalPage=Lifescience+Today.News
Area :
Cardiovascular

Category :
Scientific - Pipeline - Regulatory

Related companies :
ISCHEMIX

Related drugs :
CMX-2043


]]> Mon, 08 Mar 2010 23:00:00 GMT News Lithera Reports Positive Phase IIa Clinical Study Results for LIPO-102, a Novel Treatment for Localized Fat Reduction http://www.lifescience-online.com/Lithera_Reports_Positive_Phase_IIa_Clinical_Study_,20228.html?portalPage=Lifescience+Today.News
Area :
Metabolic Disease

Category :
Scientific - Pipeline - Regulatory

Related companies :
LITHERA INC

Related drugs :
LIPO-102


]]> Mon, 08 Mar 2010 23:00:00 GMT News Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus http://www.lifescience-online.com/Chimerix_Initiates_Phase_2_Study_of_CMX001_in_Stem,20229.html?portalPage=Lifescience+Today.News
Area :
Anti-Infective

Category :
Scientific - Pipeline - Regulatory

Related companies :
CHIMERIX INC

Related drugs :
CMX-001


]]> Mon, 08 Mar 2010 23:00:00 GMT News Cellectar, Inc. Completes Enrollment in Phase I Clinical Trial of Lead Drug Candidate (131)I-CLR1404 for the Treatment of Solid Malignancies http://www.lifescience-online.com/Cellectar__Inc__Completes_Enrollment_in_Phase_I_Cl,20230.html?portalPage=Lifescience+Today.News
Area :
Oncology

Category :
Scientific - Pipeline - Regulatory

Related companies :
CELLECTAR INC

Related drugs :
(131I)-CLR-1404


]]> Mon, 08 Mar 2010 23:00:00 GMT News Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53) http://www.lifescience-online.com/Bristol_Myers_Squibb_and_AstraZeneca_Announce_the_,20232.html?portalPage=Lifescience+Today.News
Area :
Metabolic Disease

Category :
Scientific - Pipeline - Regulatory

Related companies :
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO

Related drugs :
SAXAGLIPTIN


]]> Mon, 08 Mar 2010 23:00:00 GMT News New Data Presented at American Burn Association's Annual Meeting Support Safety Profile of RECOTHROM(R) Thrombin, Topical (Recombinant) in Pediatric Patients http://www.lifescience-online.com/New_Data_Presented_at_American_Burn_Association_s_,20235.html?portalPage=Lifescience+Today.News
Area :
Hematology

Category :
Scientific - Pipeline - Regulatory

Related companies :
ZYMOGENETICS INC

Related drugs :
RTHROMBIN


]]> Mon, 08 Mar 2010 23:00:00 GMT News